Metastatic castration-resistant prostate neoplasms Clinical Trials
Conditions / Metastatic castration-resistant prostate neoplasms
Delta Trials tracks 2 clinical trials for Metastatic castration-resistant prostate neoplasms in its publicly accessible dataset. Among the listed trials, 2 open for participant enrollment and 0 trials have reached completion. This research is carried out at 83 clinical sites around the world. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
2
Total Trials
2
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
83
Study Locations
Browse by location (83 total)
- Kurralta Park, Australia 2 trialsAll trials in Kurralta Park, Australia
- New York, United States 2 trialsAll trials in New York, United States
- Melbourne, Australia 2 trialsAll trials in Melbourne, Australia
- Madrid, Spain 2 trialsAll trials in Madrid, Spain
- Mineola, United States 2 trialsAll trials in Mineola, United States
- Woolloongabba, Australia 2 trialsAll trials in Woolloongabba, Australia
- Brooklyn, United States 2 trialsAll trials in Brooklyn, United States
- Warsaw, Poland 1 trialAll trials in Warsaw, Poland
- Fukuoka, Japan 1 trialAll trials in Fukuoka, Japan
- La Louvière, Belgium 1 trialAll trials in La Louvière, Belgium
- Taoyuan District, Taiwan 1 trialAll trials in Taoyuan District, Taiwan
- Lancaster, United States 1 trialAll trials in Lancaster, United States
- Seoul, South Korea 1 trialAll trials in Seoul, South Korea
- Pittsburgh, United States 1 trialAll trials in Pittsburgh, United States
- Greer, United States 1 trialAll trials in Greer, United States
- Nashville, United States 1 trialAll trials in Nashville, United States
- Lakewood, United States 1 trialAll trials in Lakewood, United States
- Meguro-ku,, Japan 1 trialAll trials in Meguro-ku,, Japan
- Meguro-ku, Japan 1 trialAll trials in Meguro-ku, Japan
- Meguro Ku, Japan 1 trialAll trials in Meguro Ku, Japan